Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer

NCT07730138 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

384

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Ulcer

Interventions

DRUG: DWP14012 40mg (Fexuprazan)
DRUG: Lansoprazole 30mg

Sponsor

Daewoong Pharmaceutical Co. LTD.